Prantae was founded in 2015 by two young researchers, Sumona and Aseem, who had endured Pre-eclampsia first-hand. 25th week into a 'seemingly' normal pregnancy with all measurable parameters within acceptable limits, Sumona started bloating up a little, blurry vision and little loss of balance during climbing down stairs...pretty normal right. However, the couple did one right thing- revisit their O&G even though everything appeared normal during the last ANC done just 7-days ago. Immediate hospitalization and 72 hrs later, their daughter was delivered by an emergency C-section as Sumona was going into seizure due to high blood pressure. All prophylaxis failed. Their daughter came to this world weighing just 900g. For the next 45 days, the baby was put into an extremely well-kept NICU and survived the ordeals of the early days and has now grown to be a fine girl of 7 years. But not every mother-to-be who lands up in a complicated pregnancy is fortunate as much. Had there been a way to know that Pre-eclampsia was building up during the pregnancy, there were well defined ways to manage it and thwart the fatalities.
Does that not resonate with so many other diseases of the modern day. Diabetes, epilepsy and cancer, to name just a few.
With complimentary skills in research and administration, they decided to solve over-looked problems the 'tech-way'. Prantae, is not simply a company of talented individuals aiming high. Like a pack of wolves, they will works relentlessly to make molecular prognosis possible. By merging frontier technologies in plasmonics and optofluidics. Prantae, is committed to develop 'affordable molecular prognostics' for all irreversible diseases. It professes that 'Know it well before, so that you can Prevent it'.